What Researchers Did
Researchers conducted a controlled study with 50 patients experiencing sudden hypoacusis, randomizing 30 to hyperbaric oxygen therapy (HOT) and 20 to intravenous vasodilator treatment for 10 days, evaluating hearing threshold changes.
What They Found
The 30 patients receiving hyperbaric oxygen therapy (HOT) experienced a significantly greater response to treatment compared to the 20 patients in the vasodilator group, regardless of age and sex. Significantly more patients in the HOT group achieved a good or significant response, and those with pantonal hypoacusis responded better in both treatment arms.
What This Means for Canadian Patients
Canadian patients experiencing sudden hearing loss may find hyperbaric oxygen therapy to be a more effective treatment option for improving hearing outcomes. This could lead to better recovery rates for individuals with this condition, potentially reducing the impact of severe deafness.
Canadian Relevance
This study has no direct Canadian connection as it was conducted outside of Canada.
Study Limitations
Limitations include the relatively small sample size of 50 patients and the single-center nature of the study.